Wealth
Bill Ackman ’s portfolios have suffered the worst performance patch in his career which is also caused some investors to flee.
Hi, what are you looking for?
Jewish Business News
All posts tagged "Valeant Pharmaceuticals"
Business
Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company’s leading investors, hedge fund manager William...
Business
CEO Michael Pearson has been admitted for “severe” pneumonia, an emailed statement from Valeant spokeswoman Laurie Little says. J. Michael Pearson, 56, was...
Business
From 2010, Valeant shares rose more than 10-fold to peak in August. Unfortunately, from a systemic perspective, just about every American is worse...
Business
Bill Ackman is about to hold a call defending his position in Valeant Pharmaceuticals. And ahead of this call, Herbalife, the nutritional supplement company...
Business
Bill Ackman’s Pershing Square Capital, got pounded in September. The hedge fund was the best-performing last year, returning 40.4%. Last month the fund’s publicly...
Business
Could Valeant Be the hunted this year instead of the hunter?
Business
Comparing Carl Icahn and Bill Ackman shows not all activist investing is created equal
Business
Allergan's David Pyott had to fight Bill Ackman Day and Night to avoid a takeover by Valeant.
Business
– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and...